Michael van Es

Associate Professor - medical

Strategic program(s):

Strategic program(s):

Contact

Research groups

Clinical spectrum of motor neuron disease

Research aim

Motor neuron disease (MND) are a collection of disorder that primarily lead to progressive weakness and/or spasticity. The goal is better understand and treat the extensive clinical heterogeneity in MND.

Go to group

Recent publications

Primary Lateral Sclerosis Bálint S de Vries, Eva Maria Johanna de Boer, Frans Brugman, Philip Van Damme, Jan Herman Veldink, Michael A van Es, Leonard H van den Berg
Neurology, 2025, vol. 104
Cognitive impairment within and beyond the FTD spectrum in ALS Annebelle Michielsen, Kevin van Veenhuijzen, Fenna Hiemstra, Ilse M Jansen, Boaz Kalkhoven, Jan H Veldink, Esther T Kruitwagen, Michael van Es, Martine J E van Zandvoort, Leonard H van den Berg, Henk-Jan Westeneng
Journal of Neurology, 2025, vol. 272
Neuroimaging correlates of domain-specific cognitive deficits in amyotrophic lateral sclerosis Harold H.G. Tan, Abram D. Nitert, Kevin van Veenhuijzen, Stefan Dukic, Martine J.E. van Zandvoort, Jeroen Hendrikse, Michael A. van Es, Jan H. Veldink, Henk Jan Westeneng, Leonard H. van den Berg
NeuroImage: Clinical, 2025, vol. 45
Diagnosing primary lateral sclerosis Eva M J de Boer, Bálint S de Vries, Wim Van Hecke, Angelika Mühlebner, Koen L Vincken, Christian P Mol, Wouter van Rheenen, Henk-Jan Westeneng, Jan H Veldink, Günter U Höglinger, Huw R Morris, Irene Litvan, Joost Raaphorst, Nicola Ticozzi, Philippe Corcia, Wim Vandenberghe, Yolande A L Pijnenburg, Harro Seelaar, Caroline Ingre, Philip Van Damme, Leonard H van den Berg, Bart P C van de Warrenburg, Michael A van Es
Journal of Neurology, 2024, vol. 272
Longitudinal Magnetic Resonance Imaging in Asymptomatic C9orf72 Mutation Carriers Distinguishes Phenoconverters to Amyotrophic Lateral Sclerosis or Amyotrophic Lateral Sclerosis With Frontotemporal Dementia Kevin van Veenhuijzen, Harold H.G. Tan, Abram D. Nitert, Michael A. van Es, Jan H. Veldink, Leonard H. van den Berg, Henk Jan Westeneng
Annals of Neurology, 2024, vol. 97, p.281-295
ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes Renata Vieira de Sá, Emma Sudria-Lopez, Marta Cañizares Luna, Oliver Harschnitz, Dianne M A van den Heuvel, Sandra Kling, Danielle Vonk, Henk-Jan Westeneng, Henk Karst, Lauri Bloemenkamp, Suzy Varderidou-Minasian, Domino K Schlegel, Mayte Mars, Mark H Broekhoven, Nicky C H van Kronenburg, Youri Adolfs, Vamshidhar R Vangoor, Rianne de Jongh, Tijana Ljubikj, Lianne Peeters, Sabine Seeler, Enric Mocholi, Onur Basak, David Gordon, Fabrizio Giuliani, Tessa Verhoeff, Giel Korsten, Teresa Calafat Pla, Morten T Venø, Jørgen Kjems, Kevin Talbot, Michael A van Es, Jan H Veldink, Leonard H van den Berg, Pavol Zelina, R Jeroen Pasterkamp
Nature Communications, 2024, vol. 15